Additional file 2 of Anticancer bispecific antibody R&D advances: a study focusing on research trend worldwide and in China

Fan Luo (398044); Feiteng Lu (6431666); Hongyun Zhao (285512); Jiaxin Cao (8824682); Kangmei Zeng (8205279); Li Zhang (8200); Yang Zhang (30734); Yuxiang Ma (522295); Zhonghan Zhang (11283454)

image

Additional file 2 of Anticancer bispecific antibody R&D advances: a study focusing on research trend worldwide and in China

Authors: Fan Luo (398044)
Feiteng Lu (6431666)
Hongyun Zhao (285512)
Jiaxin Cao (8824682)
Kangmei Zeng (8205279)
Li Zhang (8200)
Yang Zhang (30734)
Yuxiang Ma (522295)
Zhonghan Zhang (11283454)
Publication date: 16 August 2021
Publisher
Doi

Abstract

Additional file 2. Fig. S1: Geographic distribution of anticancer bsAbs clinical trials. (A) Clinical trials of worldwide companies. (B) Clinical trials of China-initiated or involved R&D pharmaceutical companies

Similar works

Full text

Available Versions

The Francis Crick Institute

oai:figshare.com:article/15179...

Last time updated on 17/08/2021